MDVN

Medivation, Inc. News Headlines

$48.75
*  
1.34
  negative  
2.83%
Get MDVN Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

How the bulls are trading Medivation
4/22/2013 1:20:11 PM - optionMONSTER

Can Bristol-Myers Squibb Compete In Immuno-Oncology?
4/8/2013 12:10:00 AM - Seeking Alpha

Dendreon's Provenge Ads: Are They Working?
4/3/2013 11:43:00 AM - Seeking Alpha

Astellas/MDVN Provide Update on Xtandi - Analyst Blog
4/2/2013 5:24:15 PM - Zacks.com

Medivation: Interim Analysis For PREVAIL Trial Expected To Occur In 2013
4/1/2013 7:11:00 AM - RTT News

Good News for Nymox's Pipeline - Analyst Blog
3/21/2013 6:23:03 PM - Zacks.com

Merck-Luminex' Alzheimer's Collaboration - Analyst Blog
3/19/2013 4:47:42 PM - Zacks.com

Medivation: Early Launch Of Xtandi Appears Solid
3/6/2013 7:15:00 AM - Seeking Alpha

Pluristem & UTHR Progress with PLX-PAD - Analyst Blog
3/4/2013 6:25:01 PM - Zacks.com

Medivation Beats 4Q Expectations - Analyst Blog
3/1/2013 10:00:01 AM - Zacks.com

Pipeline Advances at Isis Pharma - Analyst Blog
2/28/2013 5:28:00 PM - Zacks.com

After-Hours Earnings Report for February 28, 2013 : CRM, GPS, UHS, TEG, NGD, WR, MDVN, ENDP, GXP, MDR, CPNO, SLXP
2/28/2013 3:00:05 PM - NASDAQ.com News

Glaxo Shells Out $7.5 Million - Analyst Blog
2/26/2013 7:50:01 PM - Zacks.com

Cubist Pharma Inks Deal - Analyst Blog
2/26/2013 6:25:01 PM - Zacks.com

Dendreon Reports Narrower Loss - Analyst Blog
2/26/2013 10:10:01 AM - Zacks.com

Dendreon: Startling Results Sequencing Provenge After Medivation's Xtandi
2/25/2013 6:01:00 AM - Seeking Alpha

Gilead and Teva Bury the Hatchet - Analyst Blog
2/21/2013 2:30:01 PM - Zacks.com

Gilead Presents Positive HCV Data - Analyst Blog
2/20/2013 2:30:01 PM - Zacks.com

Pipeline Progress at Bayer/Regeneron - Analyst Blog
2/19/2013 6:15:01 PM - Zacks.com

Earnings Beat at Pharmacyclics - Analyst Blog
2/19/2013 12:00:01 PM - Zacks.com

Eylea Drives Regeneron - Analyst Blog
2/15/2013 3:32:01 PM - Zacks.com

Alexion 4Q Tops on Both Lines - Analyst Blog
2/14/2013 4:09:01 PM - Zacks.com

Priority FDA Review for Celgene Drug - Analyst Blog
2/12/2013 5:40:01 PM - Zacks.com

Biotech Mid Caps, Dangerous Slippery Slopes
2/12/2013 3:30:00 PM - Seeking Alpha

Loss at MannKind Wider than Expected - Analyst Blog
2/12/2013 12:45:35 PM - Zacks.com